Mycronic AB (publ)
MICLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $20 | $12 | $13 | $11 |
| - Cash | $3 | $2 | $1 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $17 | $11 | $12 | $11 |
| Revenue | $7 | $6 | $5 | $5 |
| % Growth | 23.7% | 11.5% | 10.4% | – |
| Gross Profit | $4 | $3 | $2 | $2 |
| % Margin | 52.7% | 50.1% | 44.7% | 49.3% |
| EBITDA | $2 | $1 | $1 | $1 |
| % Margin | 33.5% | 24.3% | 21.7% | 24.9% |
| Net Income | $2 | $1 | $1 | $1 |
| % Margin | 23.8% | 17.5% | 14.5% | 17.9% |
| EPS Diluted | 8.62 | 5.11 | 3.8 | 4.24 |
| % Growth | 68.7% | 34.5% | -10.4% | – |
| Operating Cash Flow | $2 | $2 | $1 | $1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $2 | $1 | $1 | $1 |